Starling Oncology, Inc. Marketable Securities (Current)
Starling Oncology, Inc. (STLN) had Marketable Securities (Current) of $0 as of 2024-12-31, per its 10-K filed 2025-03-26.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:MarketableSecuritiesCurrent · last filed 2025-03-26
- 2024-12-31: Marketable Securities, Current $0.00.
- 2024-09-30: Marketable Securities, Current $0.00.
- 2024-06-30: Marketable Securities, Current $9.94M.
- 2024-03-31: Marketable Securities, Current $29.78M.
| Period end | Marketable Securities, Current |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-26 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-13 |
| 2024-06-30 | $9.94M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $29.78M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $49.37M 10-K · filed 2025-03-26 |
| 2023-09-30 | $59.88M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $10.29M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $40.13M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $59.80M 10-K · filed 2024-03-28 |
| 2022-09-30 | $29.15M 10-Q · filed 2022-11-09 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-16 |